1. Home
  2. PTGX vs PENN Comparison

PTGX vs PENN Comparison

Compare PTGX & PENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • PENN
  • Stock Information
  • Founded
  • PTGX 2006
  • PENN N/A
  • Country
  • PTGX United States
  • PENN
  • Employees
  • PTGX N/A
  • PENN N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • PENN Hotels/Resorts
  • Sector
  • PTGX Health Care
  • PENN Consumer Discretionary
  • Exchange
  • PTGX Nasdaq
  • PENN Nasdaq
  • Market Cap
  • PTGX 3.3B
  • PENN 2.8B
  • IPO Year
  • PTGX 2016
  • PENN N/A
  • Fundamental
  • Price
  • PTGX $58.97
  • PENN $20.23
  • Analyst Decision
  • PTGX Strong Buy
  • PENN
  • Analyst Count
  • PTGX 8
  • PENN 0
  • Target Price
  • PTGX $70.13
  • PENN N/A
  • AVG Volume (30 Days)
  • PTGX 646.3K
  • PENN 3.8M
  • Earning Date
  • PTGX 08-06-2025
  • PENN 08-07-2025
  • Dividend Yield
  • PTGX N/A
  • PENN N/A
  • EPS Growth
  • PTGX N/A
  • PENN N/A
  • EPS
  • PTGX 0.80
  • PENN N/A
  • Revenue
  • PTGX $209,180,000.00
  • PENN $6,745,700,000.00
  • Revenue This Year
  • PTGX N/A
  • PENN N/A
  • Revenue Next Year
  • PTGX $185.11
  • PENN N/A
  • P/E Ratio
  • PTGX $73.40
  • PENN N/A
  • Revenue Growth
  • PTGX N/A
  • PENN 7.33
  • 52 Week Low
  • PTGX $33.31
  • PENN $13.25
  • 52 Week High
  • PTGX $61.89
  • PENN $23.08
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 57.69
  • PENN 70.66
  • Support Level
  • PTGX $55.26
  • PENN $19.52
  • Resistance Level
  • PTGX $58.79
  • PENN $20.11
  • Average True Range (ATR)
  • PTGX 2.20
  • PENN 0.55
  • MACD
  • PTGX 0.39
  • PENN 0.22
  • Stochastic Oscillator
  • PTGX 66.84
  • PENN 96.49

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About PENN PENN Entertainment Inc.

Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 85% of total sales in 2024; 15% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.

Share on Social Networks: